Aardvark Therapeutics (AARD) Cash from Operations (2024 - 2026)
Aardvark Therapeutics (AARD) reported Cash from Operations of 18869000.0 for Q1 2026, down 65.69% on a YoY basis from 54998764.27 in Q1 2025, and down 12.25% sequentially from 16810000.0 in Q4 2025.
Aardvark Therapeutics (AARD) Cash from Operations (2024 - 2026) Analysis & Trends
Aardvark Therapeutics (AARD) has 3 years of Cash from Operations data on file, last reported at 18869000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 65.69% year-over-year to 18869000.0; the trailing twelve-month figure through Mar 2026 stood at 61653000.0 (down 125.96% YoY), and the FY2025 full-year result was 54172000.0, down 199.51% from the prior year.
- Cash from Operations declined to 18869000.0 in Q1 2026, from 16810000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2190000.0 in Q1 2024 to a low of 18869000.0 in Q1 2026.
- A 3-year average of 10125333.33 and a median of 9844000.0 in 2025 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations tumbled 420.0% in 2025 and plunged 65.69% in 2026, its largest moves.
- Tracing AARD's Cash from Operations over 3 years: stood at 7727000.0 in 2024, then plunged by 117.55% to 16810000.0 in 2025, then retreated by 12.25% to 18869000.0 in 2026.
- Business Quant data shows AARD's Cash from Operations at 18869000.0 in Q1 2026, 16810000.0 in Q4 2025, and 16130000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.59 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 201.34 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.43 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.08 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.17 Mn |
| 10 | Aardvark Therapeutics | 139.40 Mn | 19.44 Mn | - | -18.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.87 Mn |
| Mar 31, 2026 | -18.87 Mn |
| Dec 31, 2025 | -16.81 Mn |
| Dec 31, 2025 | -16.81 Mn |
| Sep 30, 2025 | -16.13 Mn |
| Sep 30, 2025 | -16.13 Mn |
| Jun 30, 2025 | -9.84 Mn |
| Jun 30, 2025 | -9.84 Mn |
| Mar 31, 2025 | -11.39 Mn |
| Mar 31, 2025 | -11.39 Mn |
| Dec 31, 2024 | -7.73 Mn |
| Dec 31, 2024 | -7.73 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Jun 30, 2024 | -4.22 Mn |
| Jun 30, 2024 | -4.22 Mn |
| Mar 31, 2024 | -2.19 Mn |
| Mar 31, 2024 | -2.19 Mn |